-
Jio Platforms
1,490.00 1,423.80(%) -
Reliance Industries
1,182.00 1,611.20(%) -
NSE
1,795.00 1,878.00(%) -
Tube Investments
2,143.00 3,335.00(%) -
PTC Industries
24,750.00 26,049.95(%) -
Dalmia BharatLtd
1,403.50 1,464.85(%) -
Aeroflex
579.00 613.50(%) -
Pidilite Inds.
1,429.05 1,707.95(%) -
The Bombay Burmah
1,175.35 1,108.20(%) -
Birlasoft Ltd
352.25 473.75(%) -
Cholaman.Inv.&Fn
1,607.00 1,952.00(%) -
Billionbrains
193.00 227.00(%) -
Bajaj Finance
939.00 1,177.60(%) -
Max Healthcare
865.95 1,196.50(%) -
Adani Ports
1,869.00 1,891.80(%) -
HDFC Bank
686.40 1,017.90(%) -
M & M Fin. Serv.
256.60 253.30(%) -
Aditya Infotech
3,888.05 1,301.10(%) -
Kotak Mah. Bank
460.00 453.00(%) -
Acutaas Chemical
4,031.85 3,977.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Arvee Laboratories (India) Ltd Chemicals
- Indian Private
- BSE Code : 71824.0
- ISIN : INE006Z01016
-
Today’s Low
178.00 -
Today’s High
187.50
-
Open
178.00 -
Perv Close
178.58 -
52W Low
129.11 -
52W High
290.78
Key Indicators
-
P/E(TTM)
50.95
-
Mar.Cap (₹Cr.)
206.63
-
Div & Yield %
0.00
-
Book Value(₹)
30.66
-
Debt-Equity Ratio
4.99
-
AGM Date
28-Oct-2026
-
EPS
3.68
-
P/E Ratio
50.95
Financials Ratios
-
Debt-Equity Ratio
-
-
Mar.Cap (₹Cr.)
206.63
-
RONW (%)
-
-
ROCE (%)
-
Score Board
-
Equity (₹ in Cr.)
11.02
-
BV (₹)
30.70
-
Sales( ₹ in Cr.)
31.51
-
NP (in Cr.)
2.37
-
NP Var(%)
20.0
-
Div%
0.0
-
CPS (₹)
3.30
-
EPS (₹)
2.20
-
Traded Value (₹ in Lakhs)
206.63
-
52 Week High
290.78
-
52 Week Low
129.11
-
Price BSE
0.0
-
Price NSE
188.00
-
Market Capital( in Cr.)
206.63
-
P/C Ratio
57.80
-
P/E Ratio
87.30
-
Price Vs.BV
2.20
-
19-May-2026( 05:17)
Results - Announcements - Arvee... - Net profit of Arvee Laboratori...
-
04-May-2026( 10:51)
Corporate News - Arvee... - Arvee Laboratories (India) wil...
-
14-Feb-2026( 08:02)
Results - Announcements - Arvee... - Net profit of Arvee Laboratori...
-
06-Feb-2026( 03:26)
Corporate News - Arvee... - Arvee Laboratories (India) wil...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 31.51 | 38.49 | 30.35 | 61.35 | 40.33 | 47.38 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 31.51 | 38.49 | 30.35 | 61.35 | 40.33 | 47.38 |
| Other Income | 0.69 | 0.66 | 0.64 | 1.35 | 0.46 | 0.58 |
| Stock Adjustments | 3.53 | -1.81 | 2.18 | -0.95 | 0.76 | -0.42 |
| Total Income | 35.73 | 37.34 | 33.17 | 61.75 | 41.55 | 47.54 |
| EXPENDITURE : | ||||||
| Raw Materials | 18.19 | 18.87 | 16.87 | 38.49 | 23.19 | 29.07 |
| Power and Fuel Cost | 1.81 | 1.78 | 1.82 | 2.38 | 1.60 | 1.72 |
| Employee Cost | 6.03 | 6.25 | 5.93 | 6.14 | 5.69 | 5.54 |
| Other Manufacturing Expenses | 2.30 | 2.47 | 2.25 | 2.15 | 1.85 | 1.63 |
| Selling and Administration Expenses | 3.34 | 3.65 | 2.50 | 3.42 | 2.97 | 2.74 |
| Miscellaneous Expenses | 0.17 | 0.04 | 0.22 | 0.54 | 0.11 | 0.22 |
| Employee Benefit Expenses | 6.03 | 6.25 | 5.93 | 6.14 | 5.69 | 5.54 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 31.85 | 33.07 | 29.59 | 53.12 | 35.41 | 40.91 |
| Operating Profit | 3.87 | 4.27 | 3.58 | 8.64 | 6.14 | 6.63 |
| Interest | 0.23 | 0.25 | 0.25 | 0.39 | 0.37 | 0.58 |
| Gross Profit | 3.64 | 4.02 | 3.33 | 8.25 | 5.77 | 6.05 |
| Depreciation | 1.21 | 1.15 | 1.50 | 2.08 | 2.32 | 2.41 |
| Profit Before Tax | 2.43 | 2.87 | 1.83 | 6.17 | 3.45 | 3.64 |
| Current Tax | 0.38 | 0.58 | 0.43 | 1.75 | 0.99 | 1.07 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.47 | 0.14 | 0.35 | 0.30 | -0.11 | -0.11 |
| Reported Net Profit | 2.53 | 2.15 | 1.05 | 4.12 | 2.57 | 2.68 |
| Extraordinary Items | 0.15 | 0.17 | 0.04 | 0.01 | 0.09 | 0.19 |
| Adjusted Net Profit | 2.38 | 1.98 | 1.01 | 4.11 | 2.48 | 2.49 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | -0.07 | 0.00 |
| P & L Balance brought forward | 18.31 | 16.16 | 15.11 | 10.99 | 8.48 | 5.80 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| P & L Balance carried down | 20.83 | 18.31 | 16.16 | 15.11 | 10.99 | 8.48 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Per Share(Rs) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings Per Share-Unit Curr | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 |
| Earnings Per Share(Adj)-Unit Curr | 2.29 | 1.95 | 0.95 | 3.74 | 2.34 | 2.43 |
| Book Value | 30.66 | 28.37 | 26.42 | 25.46 | 21.73 | 19.45 |
| Book Value(Adj)-Unit Curr | 30.66 | 28.37 | 26.42 | 25.46 | 21.73 | 19.45 |
